The innovator who breaks limiting beliefs
Dilrini De Silva is looking to make a global health impact by improving treatment options for ethnic minority populations with her biotech firm Jāna Bio. Dilrini founded pre-seed biotech start-up Jāna Bio alongside postdoctoral associates at the University of Cambridge. Their aim is to have a major impact in the treatment options available for ethnic minorities currently underrepresented in medicines development.
Dilrini’s project will assess the feasibility of developing an integrated technology platform, combining artificial intelligence with state-of-the-art stem cell engineering techniques. The goal is to generate novel insights for pharmacogenomic applications and patient selection for clinical trials.
By winning the Women in Innovation Award, Dilrini will be able to create a data package to attract follow-on funding, key team members, and research and development partners in order to further develop the technology.
This award presents an opportunity to play a key role in shaping treatment options that better represent people like me, my family and billions in the Global South.